rss
J Clin Pathol 2007;60:104-106 doi:10.1136/jcp.2006.036715
  • Short report

Aberrant gene methylation implicated in the progression of monoclonal gammopathy of undetermined significance to multiple myeloma

  1. Chor-Sang Chim,
  2. Raymond Liang,
  3. Man-Hin Leung,
  4. Yok-Lam Kwong
  1. University Department of Medicine, Queen Mary Hospital, Hong Kong
  1. Correspondence to:
    Dr C-S Chim
    Department of Medicine, Queen Mary Hospital, Pokfulam Road, Hong Kong 852, Hong Kong; jcschim{at}hku.hk
  • Accepted 24 February 2006

Abstract

Malignant transformation is a multistep process that may involve dysregulation of oncogenes and tumour suppressor genes, and monoclonal gammopathy of undetermined significance (MGUS) is believed to be a precursor of multiple myeloma. To investigate whether aberrant promoter methylation might be involved in the evolution of MGUS to multiple myeloma, we examined the p16, protein tyrosine phosphatase, non-receptor type 6 (SHP1), death-associated protein (DAP) kinase, E-cadherin and oestrogen receptor genes, most being tumour suppressor genes, by methylation-specific polymerase chain reaction. In 32 cases of multiple myeloma and 19 cases of MGUS, significantly more frequent methylation of p16 (p = 0.001), SHP1 (p≤0.001) and E-cadherin (p≤0.001) genes was found in multiple myeloma than in MGUS. Methylation of DAP kinase and oestrogen receptor genes was comparable in multiple myeloma and MGUS. In conclusion, methylation of p16, SHP1 and E-cadherin genes might be involved in the progression of MGUS to multiple myeloma.

Footnotes

  • Competing interests: None declared.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.